Rigel Pharmaceuticals (RIGL) EPS (Basic) (2010 - 2026)
Rigel Pharmaceuticals' (RIGL) quarterly EPS (Basic) came in at $0.47 in Q1 2026, down 26.87% year-on-year from $0.64 in Q1 2025, and down 96.85% quarter-over-quarter from $14.9 in Q4 2025.
Rigel Pharmaceuticals (RIGL) EPS (Basic) (2010 - 2026) Analysis & Trends
Rigel Pharmaceuticals' EPS (Basic) history runs 17 years deep, the most recent figure standing at $0.47 for Q1 2026.
- On a quarterly basis, EPS (Basic) fell 26.87% year-over-year to $0.47 in Q1 2026; TTM through Mar 2026 was $19.78, a 847.56% increase from a year earlier, with the FY2025 full-year figure at $20.4, up 1951.47% from the prior year.
- EPS (Basic) slipped to $0.47 in Q1 2026 per RIGL's latest filing, from $14.9 in the prior quarter.
- Across five years, EPS (Basic) topped out at $14.9 in Q4 2025 and bottomed at -$1.6 in Q1 2022.
- The 5-year median for EPS (Basic) is $0.0 (2023), against an average of $1.0.
- Across the five-year window, EPS (Basic) plunged 168.68% in 2022 and jumped 128957.8% in 2024, its largest moves.
- Year by year, EPS (Basic) stood at $0.08 in 2022, then plunged by 99.22% to $0.0 in 2023, then soared by 128957.8% to $0.82 in 2024, then jumped by 1726.82% to $14.9 in 2025, then slumped by 96.85% to $0.47 in 2026.
- Per Business Quant, the three latest RIGL EPS (Basic) figures stand at $0.47 (Q1 2026), $14.9 (Q4 2025), and $1.55 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Rigel Pharmaceuticals | 674.25 Mn | 527.57 Mn | 54.21 Mn | 0.47 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.47 |
| Dec 31, 2025 | 14.90 |
| Sep 30, 2025 | 1.55 |
| Jun 30, 2025 | 3.33 |
| Mar 31, 2025 | 0.64 |
| Dec 31, 2024 | 0.82 |
| Sep 30, 2024 | 0.71 |
| Jun 30, 2024 | -0.06 |
| Mar 31, 2024 | -0.47 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | -0.33 |
| Jun 30, 2023 | -0.38 |
| Mar 31, 2023 | -0.78 |
| Dec 31, 2022 | 0.08 |
| Sep 30, 2022 | -1.10 |
| Jun 30, 2022 | -0.78 |
| Mar 31, 2022 | -1.60 |
| Dec 31, 2021 | -1.33 |
| Sep 30, 2021 | -1.23 |
| Jun 30, 2021 | -0.81 |